Phone counseling helps latinas navigate cancer risk
NCT ID NCT01230346
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a culturally-informed telephone counseling program can help Latina women at high risk for hereditary breast or ovarian cancer learn more about their risk and feel more in control. About 493 women with a personal or family history of these cancers will take part. The goal is to see if this approach reduces anxiety and improves knowledge compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- counseling intervention
- What this could lead to
- If successful, this could show that a tailored phone counseling program helps Latinas better understand their cancer risk and feel more in control.
- What could go wrong
- This is a pilot study focused on education and decision-making, not a treatment. It may not change health outcomes or be widely adopted.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
493 people
The number who actually took part.
- Started
-
Sep 2010
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Individuals who have a personal history of hereditary breast or ovarian cancer; a subset of 60 women without a personal history of hereditary or ovarian cancer will be included in an exploratory subset analysis * Meet NCCN criteria for consideration of genetic testing for hereditary breast cancer * Willing to sign consent * Pregnant women and women of child-bearing potential are eligible for participation in this study * Women who report themselves to be of Latino or Hispanic ethnic background (defined as Spanish, Mexican, Central or South American, Cuban, Puerto Rican, Dominican, or other Hispanic origin) * Women who are under- or uninsured and come from low-income communities * Ability to understand English or Spanish Exclusion Criteria: * Previous participation in GCRA
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRCA1 syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
Olive View-UCLA Medical Center
Sylmar, California, 91342, United States
-
University of Southern California-Keck School of Medicine
Los Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.